Biomarker assessment and genetic testing are most valuable for patients planning long-term GLP-1 treatment, those with a family history of treatment-side-effect sensitivity, or individuals seeking to understand why their response differs from peers
That means patients who start medication through this program in July 2026 could lose coverage in January 2028 if Congress doesnt act to extend or replace it
Risks Nausea, vomiting, constipation, and diarrhea are the most common side effects, but they tend to improve with time
N-acetylcysteine (NAC) is a supplement form of the amino acid cysteine
McCaddon A, Hudson P, Hill D, Barber J, Lloyd A, Davies G, et al
KLOW can begin roughly 4872 hours after minor procedures, once the initial inflammatory cascade has peaked, with any new compounds held through the acute first week